Because of the rarity of endocrine tumors and the limited number of dedicated endocrine oncology programs, many patients with these conditions end up being treated by providers who do not specialize in endocrine oncology. Dedicated endocrine oncology programs can therefore serve as a significant program differentiator and patient attractor, while also improving patient care and surgical outcomes.
This report provides guidance to strategic planners of institutions that are considering developing an endocrine oncology program. It provides an overview of the endocrine tumor conditions seen by endocrine oncology programs, describes common treatment pathways for endocrine tumor patients, reviews new treatment and technology trends, details the clinical staffing needs of such programs, and outlines strategies for program growth.
Next, check out
Ready-to-use slides for strategic planners and service line leaders